Type of site | Prescription drug marketplace |
|---|---|
| Available in | English |
| Owner | White House Office |
| URL | trumprx.gov |
| Launched | February 5, 2026 |
TrumpRx is a prescription drug website operated by the United States federal government. It was created in 2026.
Type of site | Prescription drug marketplace |
|---|---|
| Available in | English |
| Owner | White House Office |
| URL | trumprx.gov |
| Launched | February 5, 2026 |
TrumpRx is a prescription drug website operated by the United States federal government. It was created in 2026.
In September 2025, Bloomberg News reported that Trump administration officials were considering establishing a website to partially fulfill U.S. president Donald Trump's demands that drugmakers reduce their prices to levels set by other countries. [1] On September 30, Trump announced TrumpRx from the Oval Office, joined by Pfizer chief executive Albert Bourla. [2] The website was set to go online in January 2026. [3]
The TrumpRx website did not launch as scheduled in January 2026. During a cabinet meeting at the White House on January 29, Health and Human Services Secretary Robert F. Kennedy Jr. mentioned that the website will be operational "in 10 days," although no specific launch date was provided. [4]
The website was launched on February 5, 2026. [5]
TrumpRx is a website that offers prescription drugs at a discounted price. [2] The prices are benchmarked against those in Europe. [3] Pfizer's negotiated discounts ranged from fifty to eighty-five percent. [6]
The website does not sell drugs directly. Rather, it enables consumers to buy specific prescription medications directly from pharmaceutical companies at reduced prices, without going through their insurance. The aim is to reduce out-of-pocket expenses for consumers, especially those who pay cash or do not have extensive drug coverage. [7]
The website is designed by the National Design Studio. [8]
According to an initial statement from the Trump administration, TrumpRx will provide Eucrisa, Xeljanz, and Zavzpret. [2] In October 2025, the Trump administration reached a deal with AstraZeneca; [9] a website from AstraZeneca, named AstraZeneca Direct, [10] included Farxiga, Airsupra, and FluMist as eligible for direct pricing. [9] That month, EMD Serono agreed to offer its gonadotropin preparation drugs, including Gonal-f, [11] on TrumpRx. [12] AmgenNow, a website from Amgen that offers Repatha, is additionally set to appear on TrumpRx. [13]
At its launch on February 5, 2026, 43 drugs are available on TrumpRx. [14] The White House plans to add more drugs over time. [15]
Bloomberg News described TrumpRx as an instance of Trump using the federal government as an avenue for shareholder activism. [16]
California Governor Gavin Newsom described TrumpRx as a copy of CalRx, which set the insulin price at a maximum of $11. [17]
Democratic Senators Dick Durbin, Elizabeth Warren, and Peter Welch raised concerns regarding questionable prescribing practices, potential conflicts of interest, and insufficient care related to the specific types of direct-to-consumer (DTC) platforms to which TrumpRx would direct patients. [18]
The deal reached with the Trump administration secured Pfizer a reprieve from tariffs on the pharmaceutical industry, threatened to be 100 percent. [19]
According to The New York Times , TrumpRx does not provide meaningful discounts for insurance beneficiaries. [20]
Second presidency of Donald Trump (2025–present) | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| General |
| ||||||||||||||
| Events |
| ||||||||||||||
| Policies |
| ||||||||||||||
| Democratic backsliding |
| ||||||||||||||
| Protests |
| ||||||||||||||
| Related |
| ||||||||||||||
